Chenodeoxycholic acid glycine conjugate
|
Basic information |
| Metabolite name | Chenodeoxycholic acid glycine conjugate |
 | HMDB0000637 |
 |
C05466 |
 |
12544 |
| Synonyms | Glycochenodeoxycholate; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Chenodeoxycholic acid glycine conjugate |
| HMDB0000637 |
|
C05466 |
|
12544 |
| Synonyms | Glycochenodeoxycholate; |
| No. of studies | 6 |
|
Relationship between Chenodeoxycholic acid glycine conjugate and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1101 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Up |
| Study M867 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Plasma | Sprague-Dawley rat | Unknown |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Up |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |